Two unusual cases of toxic epidermal necrolysis

Australasian Journal of Dermatology

Volumn 43, Issue 1, 2002, Pages 35-38

  Yung, Anthony ^a,b   Agnew, Karen ^a   Snow, John ^a   Oliver, Fergus ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Amiodarone; Dexamphetamine; Ephedrine; Lyell's Syndrome

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMPHETAMINE; EPHEDRINE; IMMUNOGLOBULIN; PENTOXIFYLLINE; STEROID; THALIDOMIDE;

ADULT; AGED; ARTICLE; BLISTER; BODY SURFACE; CASE REPORT; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG INDUCED DISEASE; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HUMAN TISSUE; LIP; PAPULE; PLEURA EFFUSION; PNEUMONIA; RASH; SEPTICEMIA; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; AMIODARONE; BIOPSY, NEEDLE; CYCLOSPORINS; DEXTROAMPHETAMINE; EPHEDRINE; EPIDERMAL NECROLYSIS, TOXIC; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036181118     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2002.00549.x     Document Type: Article

References (37)

1. Drug-induced toxic epidermal necrolysis
2. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-92): Structure and results of a population based registry
3. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
4. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome)
5. Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis
6. Characteristics of toxic epidermal necrolysis in patients undergoing long term glucocorticoid therapy
7. Toxic epidermal necrolysis and amiodarone treatment
8. Amiodarone
9. Diltiazem
10. Immunopathology of toxic epidermal necrolysis
11. Two divergent findings in TEN
12. Macrophages and tumor necrosis factor α in toxic epidermal necrolysis
13. Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response
14. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
15. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
16. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulphonamides and anticonvulsants
17. Improving outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome
18. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death?
19. Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn centre
20. Nutritional requirements in patients with toxic epidermal necrolysis
21. Burn center care for patients with toxic epidermal necrolysis
22. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids
23. Toxic epidermal necrolysis and systemic steroids
24. Efficacy of cyclophosphamide in toxic epidermal necrolysis: Clinical and pathophysiologic aspects
25. Toxic epidermal necrolysis treated with cyclosporine
26. Toxic epidermal necrolysis treated with cyclosporine and granulocyte stimulating factor
27. Treatment of toxic epidermal necrolysis with cyclosporine A
28. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis
29. Lack of significant effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?
30. Toxic epidermal necrolysis. Treatment with pentoxifylline
31. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
32. Hyperbaric oxygen treatment of toxic epidermal necrolysis
33. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine
34. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis
35. Toxic epidermal necrolysis. Clinical findings and prognostic factors in 87 patients
36. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator
37. SCORTEN. A severity-of-illness score for toxic epidermal necrolysis